CINFALAIR PAEDIATRIC 4MG 28SACH
CINFA
SKU: 44857
Cinfalair contains the active ingredient Montelukast.
Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing, shortness of breath).
This medication can help reduce the number of times you need to use your quick-acting inhaler. Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing and stuffy/runny/itchy nose).
Cinfalair Paediatrics is used for the treatment of 6 months to 5 year old patients who are not adequately controlled on their medication and need additional therapy.
Benefits:
• Cinfalair Paediatrics improves asthma symptoms and helps control asthma.
• Cinfalair Paediatrics to treat your child’s asthma, preventing asthma symptoms during the day and night.
• Cinfalair Paediatrics may also be used as an alternative treatment to inhaled.
Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing, shortness of breath).
This medication can help reduce the number of times you need to use your quick-acting inhaler. Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing and stuffy/runny/itchy nose).
Cinfalair Paediatrics is used for the treatment of 6 months to 5 year old patients who are not adequately controlled on their medication and need additional therapy.
Benefits:
• Cinfalair Paediatrics improves asthma symptoms and helps control asthma.
• Cinfalair Paediatrics to treat your child’s asthma, preventing asthma symptoms during the day and night.
• Cinfalair Paediatrics may also be used as an alternative treatment to inhaled.
Frequently Bought Together
More From CINFA
More From Medicine
Featured Items
View all
Recently Viewed
How to apply the cream correctly?
Use this section to explain a set of product features, to link to a series of pages, or to answer common questions.
5-step skin routine you might go for
Use this section to explain a set of product features, to link to a series of pages, or to answer common questions.
